MA46100A - Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation - Google Patents

Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation

Info

Publication number
MA46100A
MA46100A MA046100A MA46100A MA46100A MA 46100 A MA46100 A MA 46100A MA 046100 A MA046100 A MA 046100A MA 46100 A MA46100 A MA 46100A MA 46100 A MA46100 A MA 46100A
Authority
MA
Morocco
Prior art keywords
ezetimibe
rosuvastatin
preparation
pharmaceutical composition
composition consisting
Prior art date
Application number
MA046100A
Other languages
English (en)
Inventor
Ondrej Dammer
Petr Mikes
Alena Prokopova
Jaroslava Svobodova
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MA46100A publication Critical patent/MA46100A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA046100A 2016-09-05 2017-08-31 Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation MA46100A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ2016-539A CZ2016539A3 (cs) 2016-09-05 2016-09-05 Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy

Publications (1)

Publication Number Publication Date
MA46100A true MA46100A (fr) 2019-07-10

Family

ID=59955311

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046100A MA46100A (fr) 2016-09-05 2017-08-31 Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation

Country Status (14)

Country Link
US (1) US11786526B2 (fr)
EP (1) EP3506888A1 (fr)
JP (1) JP7094944B2 (fr)
KR (1) KR102517765B1 (fr)
CN (1) CN110418637A (fr)
BR (1) BR112019004269A2 (fr)
CZ (1) CZ2016539A3 (fr)
EA (1) EA201990652A1 (fr)
IL (1) IL265172B (fr)
MA (1) MA46100A (fr)
MX (1) MX2019002516A (fr)
TW (1) TWI811195B (fr)
WO (1) WO2018041282A1 (fr)
ZA (1) ZA201901342B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7115825B2 (ja) * 2017-06-28 2022-08-09 日医工株式会社 エゼチミブ含有経口製剤及びその製造方法
JP2019014700A (ja) * 2017-07-11 2019-01-31 大原薬品工業株式会社 エゼチミブ含有口腔内崩壊錠及びその製造方法
WO2021019499A1 (fr) 2019-07-31 2021-02-04 TECNIMEDE - Sociedade Técnico-medicinal, SA Compositions solides orales à libération immédiate à unités multiples, procédés et utilisations de celles-ci
WO2022023206A1 (fr) * 2020-07-27 2022-02-03 Krka, D.D., Novo Mesto Comprimé bicouche comprenant de l'ézétimibe et de l'atorvastatine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1512394B1 (fr) * 2003-09-01 2008-03-26 JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composition universelle à libération controlée comprenant du chitosane
WO2009024889A2 (fr) 2007-08-21 2009-02-26 Ranbaxy Laboratories Limited Composition pharmaceutique comprenant un inhibiteur de réductase hmg-coa et un ézétimibe
EP2168573A1 (fr) 2008-09-30 2010-03-31 LEK Pharmaceuticals D.D. Formulations contentant d'ézétimibe
EP2448919A2 (fr) 2009-07-02 2012-05-09 Mahmut Bilgic Formulation pharmaceutique permettant d'augmenter la solubilité et la stabilité
WO2011012912A2 (fr) * 2009-07-28 2011-02-03 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Nouveau procédé de granulation et granulé ainsi préparé
TR201009397A2 (tr) * 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Rosuvastatin içeren farmasötik bileşimler.
WO2013066279A1 (fr) 2011-10-13 2013-05-10 Mahmut Bilgic Formes pharmaceutiques solides contenant de l'ézétimibe
PL2844233T3 (pl) 2012-05-01 2020-09-07 Althera Life Sciences, Llc Preparat w postaci tabletki do stosowania doustnego składający się ze stałego połączenia rosuwastatyny i ezetymibu w leczeniu hiperlipidemii i chorób sercowo-naczyniowych
MX2012014970A (es) * 2012-12-18 2013-08-27 Hetlabs Mexico S A De C V Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.
HU231036B1 (hu) * 2013-09-30 2019-12-30 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény
CN103585157B (zh) * 2013-11-13 2016-02-03 武汉武药科技有限公司 一种含依折麦布和瑞舒伐他汀的双层片及其制备方法
KR20150079373A (ko) * 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
KR101977785B1 (ko) * 2014-06-25 2019-05-14 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법
FR3030251B1 (fr) * 2014-12-22 2018-11-02 L'oreal Composition comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un solvant particulier
CN105310993A (zh) 2015-11-17 2016-02-10 深圳信立泰药业股份有限公司 一种含有依折麦布的药物组合物及其制备方法

Also Published As

Publication number Publication date
US20200009136A1 (en) 2020-01-09
CN110418637A (zh) 2019-11-05
MX2019002516A (es) 2019-06-17
TWI811195B (zh) 2023-08-11
EA201990652A1 (ru) 2019-08-30
EP3506888A1 (fr) 2019-07-10
JP7094944B2 (ja) 2022-07-04
IL265172B (en) 2022-09-01
IL265172A (en) 2019-05-30
WO2018041282A1 (fr) 2018-03-08
CZ2016539A3 (cs) 2018-03-14
US11786526B2 (en) 2023-10-17
JP2019526591A (ja) 2019-09-19
KR20190045286A (ko) 2019-05-02
ZA201901342B (en) 2020-10-28
KR102517765B1 (ko) 2023-04-03
TW201818938A (zh) 2018-06-01
BR112019004269A2 (pt) 2019-06-04

Similar Documents

Publication Publication Date Title
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
MA46100A (fr) Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation
MA42231A (fr) Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant
MA43709A (fr) Composition pharmaceutique comprenant de l'empagliflozine et ses utilisations
FR3037957B1 (fr) Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA51988A (fr) Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale
GB201720163D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
FR3037959B1 (fr) Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA53920A (fr) Procédé de fourniture d'administration sous-cutanée d'anticorps anti-cd38
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
MA43918A (fr) Composition pharmaceutique pour la prã‰vention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31
IL279397A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
PL3976189T3 (pl) Nowe związki i ich kompozycje farmaceutyczne do leczenia chorób
MA55291A (fr) Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques
MA50239A (fr) Procédé de formulation pharmaceutique lyophilisée d'une protéine thérapeutique
BR112016030730A8 (pt) composto
MA50487A (fr) Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique
PT3604304T (pt) Composto derivado de pirrolo-piridina, método para a sua preparação e composição farmacêutica que o contém como substância ativa para prevenção ou tratamento de doenças relacionadas com proteína quinase
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
MA44286A (fr) Formulation pharmaceutique de cinéol et d'amoxicilline
CL2014003443A1 (es) Compuestos derivados de n-[4-(quinolin-4-iloxi)ciclohexil(metil)](hetero)aril-carboxamidas; su metodo de produccion; compuestos intermediarios; producto medicinal que contiene al compuesto, util para el tratamiento y/o prevencion de enfermedades hiperproliferativas, las cuales son dependientes del receptor de androgenos.
MA51295A (fr) Dosage, procédé et traitement d'alpha-synucléinopathies
MA52587A (fr) Composés d'azabenzimidazole et produit pharmaceutique
MA49555A (fr) Procédé amélioré de préparation d'imetelstat
MA41432A (fr) Composition pharmaceutique pour le traitement de maladies gastro-intestinales